With this magazine, we hope to keep you up to date and offer you insights into the fascinating world of cancer research. Read the first edition of the Magazine to gain insight into the debate on the speed of cancer drug development, a feature on Monika Wolkers joining forces with Oncode from Sanquin, a recap on the potential of immunotherapy, and get to know more about the breakthroughs happening at Oncode Institute.
So, what’s new in this issue?
The drug development pipeline is discussed in a dialogue between patient advocate Stefan Gijssels and Oncode Investigator Emile Voest. Monika Wolkers, one of our newly appointed Oncode Investigators, shares her personal motivation to work in oncology and we immersed ourselves in the world of immunotherapy by visiting the lab of Ton Schumacher.
Feel free to share our stories and let us know what you think: we like to hear from you.